Beta Drugs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2025
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited held its 20th AGM on September 30, 2025, from 10:30 AM to 11:35 AM at its registered office in Baddi, Himachal Pradesh, with 16 members present. Chairman and Managing Director Mr. Rahul Batra chaired the meeting, and the auditor's report was noted to have no qualifications, modified opinion, or adverse remarks. Seven resolutions were put to vote via e-voting (Sept 26-29) and poll at the venue, including adoption of FY25 audited standalone and consolidated financial statements, re-appointment of two retiring directors, ratification of cost auditor remuneration for FY26, appointment of secretarial auditors, and re-appointment of Mr. Rahul Batra as CMD and Mr. Varun Batra as Joint MD for a fresh 5-year term starting January 27, 2026. Consolidated voting results were to be announced later on the company's website and shared with the stock exchange.
This is a routine regulatory filing summarizing AGM proceedings — no material new business was announced. The re-appointment of the CMD and JMD for another 5-year term signals leadership continuity, while the clean auditor's report is mildly reassuring on governance and financial reporting. Short-term stock impact is likely neutral; investors should watch for the detailed voting results when filed.